Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • atomsmith atomsmith Jul 2, 2014 12:38 PM Flag

    Its Just a Matter of Time

    Roche/Genentech will pick up IMGN. They are probably the ones selling small to keep the price down.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I am thinking it's Sanofi, we shall see. The negative MS analyst estimated peak sales of the MAb they acquired through IMGN at $1.5BB and they have 2 other molecules. He estimated peak sales for Kadcyla at $6BB+ Then he went on to say IMGN execs will waste all of the money on more failed internal programs.

      This morning I sent an email to the new CEO at Takeda suggesting his team take a look. I have been directly contacting IMGN BOD members to voice my displeasure with the current price among other things. IMGN needs to consider/reward their long suffering shareholders.

 
IMGN
5.65-0.23(-3.91%)4:00 PMEDT